# COMPANIO — PHASE 12.1: BASELINE AUDIT & EXTERNAL VALIDATION READINESS
## Pre-Pilot Verification, Reconciled Findings & Governance Inventory

**Document Reference:** `docs/PHASE_12_1_BASELINE_AUDIT.md`  
**Milestone:** Phase 12.1 — External Validation, Human Factors Testing & Controlled Pilot Authorization  
**Lead Roles:** Principal Healthcare Software Architect, Clinical Safety Engineer, Security & Privacy Officer  
**Baseline Git Commit:** `450fca1`  
**Working Tree Status:** Clean  
**Evaluation Date:** 2026-11-04  

---

## 1. Baseline Git & Codebase State

The engineering repository has been verified at commit `450fca1` on branch `main`. The working tree is clean.
The automated test harness covers 12 master suites with 100% passing status across:
- `npm run test:pilot` (Phase 12 End-to-End Controlled Pilot: 11 stages, 43 assertions)
- `npm run test:recovery` (Phase 12 Cryptographic Password Recovery: 10/10 security checks)
- `npm run test:drill` (Phase 11 Backup & Restore Drill: 1058 documents, 100% bit parity)
- `npm run test:operations` (Phase 10 Release Gates A–E, Prometheus telemetry, tracing)
- `npm run test:redis` (Phase 9.1 Live Redis 8.10.3 Engine, 8 failure injection scenarios)
- `npm run test:jobs` (Phase 9 Distributed BullMQ Queues, 7 workers, DLQ, flag preservation)
- `npm run test:caregivers` (Phase 8 Caregiver & Family Portal: 10 suites, 15 REST APIs)
- `npm run test:reporting` (Phase 7 Clinician Attestation & Reporting: 11 suites, 30 criteria)
- `npm run test:dialogue` (Phase 6 Clinical Dialogue & Observations: 77/77 checks)
- `npm run test:safety` (Phase 5 Clinical Safety Net: 9 suites, 162/162 checks)
- `npm run test:voice` (Phase 4 Hardened Voice Gateway: 8 suites, 40/40 checks)
- `npm run build:client` (Vite 5.4.21 Client Production Build)

---

## 2. Review of Phase 11 & Phase 12 Reports & Reconciliation of Claims

A rigorous audit of the completion reports from Phase 11 (`docs/PHASE_11_COMPLETION_REPORT.md`) and Phase 12 (`docs/PHASE_12_COMPLETION_REPORT.md`, `docs/PHASE_12_PRODUCTION_READINESS_MATRIX.md`) reveals a critical distinction between **engineering software validation** and **external institutional readiness**:

### 2.1 Reconciled Completion Claims vs External Realities

| Area / Claim | Reported Engineering Status | Actual External Governance Status | Reconciliation Determination |
| :--- | :--- | :--- | :--- |
| **End-to-End Clinical Lifecycle** | 100% Automated Synthetic PASS (`testPhase12EndToEndPilot.js`) | Verified in synthetic sandbox; no live patient data processed | **PASS (Stage A: Synthetic Validation)**. Validates code paths, schemas, and invariants. |
| **Password Recovery & Session Revoke** | 100% PASS (`testPasswordRecovery.js`) | Internal automated security verification | **PASS (Remediation Closed)**. Cryptographic tokens, timing defense, and session kill verified. |
| **Backup & Restore RPO/RTO** | 100% PASS (`testBackupRestoreDrill.js`) | 1058 documents restored with identical SHA-256 hash | **PASS (Remediation Closed)**. RPO < 15m, RTO < 30m verified. |
| **Third-Party Vendor Integrations** | Technical endpoints and streaming functional | **Zero executed legal BAAs** with AssemblyAI, Google, ElevenLabs, Twilio, Resend | **BLOCKED for Production PHI**. Technical readiness != legal readiness. |
| **Independent Penetration Testing** | In-house tests and automated scripts passing | No external CREST/SOC2 accredited third-party penetration test executed | **NOT VERIFIED / SCHEDULED**. Automated scripts and developer reviews do NOT count as external pentests. |
| **Clinical Governance & Taxonomy** | 13 RED + 10 YELLOW rules codified and tested | Formal multi-physician institutional review board sign-off pending | **NOT VERIFIED / PENDING EXTERNAL SIGN-OFF**. Rules must receive signed clinical review. |
| **Human Factors Usability Study** | Usability protocol documented (`PHASE_12_ACCESSIBILITY_PILOT.md`) | IRB approval pending; **zero live human participants recruited** | **NOT VERIFIED / RECRUITMENT HALTED**. Ethics approval must precede human testing. |

---

## 3. Inventory of Outstanding Gaps & Gate Requirements

To transition Companio from an engineered software artifact to a compliant, clinically validated pilot and future production system, the following 5 gating domains must be addressed:

### Gap 1: Vendor Contractual Coverage & De-Identification Safeguards
- **Problem:** Current external cloud providers (Google Cloud Gemini API, AssemblyAI, ElevenLabs, Twilio, Resend) are connected via developer/standard tier credentials without executed HIPAA Business Associate Agreements (BAAs).
- **Statutory Constraint:** Transmitting live Protected Health Information (PHI) to these providers is a federal HIPAA violation (Tier 3 / Tier 4 Willful Neglect).
- **Action Required:**
  1. Record current contractual status and terms for each provider.
  2. For any provider without a BAA, engineer a strict de-identification / PHI redaction gateway, or mandate synthetic data fallback for all pilot activities.

### Gap 2: Independent Third-Party Penetration Test Scope & Coordination
- **Problem:** Internal test suites verify expected inputs and error handling, but cannot substitute for adversarial penetration testing conducted by an external, independent cybersecurity auditing firm.
- **Action Required:** Create a formal Penetration Testing Scope and Rules of Engagement document (`docs/PHASE_12_1_PENETRATION_TEST_SCOPE.md`) covering all 12 platform surfaces (Auth, RBAC, Multi-tenancy, Socket.IO, BullMQ, Redis, Outbox, APIs, Data exports).

### Gap 3: Clinical Governance & Review Package
- **Problem:** Clinical taxonomy rules (13 RED, 10 YELLOW) and emergency interruption guidance were developed by clinical safety engineers but have not undergone formal, signed external review by independent licensed physicians and geriatric specialists.
- **Action Required:** Prepare a formal Clinical Approval Package (`docs/PHASE_12_1_CLINICAL_APPROVAL_REGISTER.md`) capturing reviewer credentials, review date, decision, and clinical conditions.

### Gap 4: Human Factors Usability Study & Ethics / IRB Approval
- **Problem:** A 15-participant protocol is specified in Phase 12, but live human testing cannot legally or ethically commence without Institutional Review Board (IRB) or Quality Improvement (QI) ethics exemption/approval.
- **Action Required:** Formally verify IRB/Ethics submission status, document informed consent procedures, and prepare study execution protocols in `docs/PHASE_12_1_HUMAN_FACTORS_RESULTS.md`.

### Gap 5: Consolidated Risk & Remediation Register
- **Problem:** Risk items are distributed across multiple Phase 10, 11, and 12 documents.
- **Action Required:** Unify all risks (Security, Privacy, Clinical, Contractual, Accessibility, Infrastructure, Operational) into a single master register (`docs/PHASE_12_1_RISK_REMEDIATION_REGISTER.md`) with explicit owners, risk ratings, and remediation status.

---

## 4. Phase 12.1 Execution Directives

1. **Strictly Non-Feature Development**: Focus entirely on governance, contracts, external audit coordination, risk registers, and pilot readiness.
2. **Zero Fabrication**: Do not fabricate signed BAAs, external audit reports, or live human participant data.
3. **Decoupled Decision Gating**:
   - Gating Decision A (Synthetic Engineering Validation): **APPROVED / PASS**
   - Gating Decision B (Restricted Human Usability Pilot): **CONDITIONAL GO (Pending IRB approval & de-identification)**
   - Gating Decision C (Controlled Clinical Pilot): **BLOCKED (Pending clinical governance & provider BAAs)**
   - Gating Decision D (Commercial Production Launch): **BLOCKED (Strict Stop Gate Enforced)**
